CTI BioPharma declares publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology Read more
Amgen declared that data from two new studies suggest barriers to access for PCSK9 inhibitors Read more
Abbott’s HeartMate 3 Heart Pump displays enhanced survival and lower rates of Stroke and Pump Thrombosis Read more